Tislelizumab
BeiGene
[]
rationale-305 finds tislelizumab (anti-pd1 ab) plus chemo is superior (hr 0.74 for os) to chemo alone in her2 negative #gastriccancer another new frontline option in the ever-evolving gastroesophageal cancer landscape #gi23
Leader, GI Oncology Unit @wilmotcancer. Researcher in #cachexia, #pancreaticcancer. Girl dad, @notredame alum, tweets opinion not medical advice